Attachment 3: New Cohort Statement of Work
Updated
A PDF document (325 KB) attached to Strong Heart Study (SHS) – New Cohort of Young Native American (NA) Adults, from the National Institutes of Health. Due Feb 24, 2027, 3:00 PM (UTC-5).
File name: Att 3 New Cohort Statement of Work_(11-12-26).pdf
The full file is for paid members, or buy this bid alone.
Preview
Attachment 3
STATEMENT OF WORK
Strong Heart Study (SHS) – New Cohort of Native American (NA) Participants I.
Background
Native Americans (NAs) experience a disproportionate burden of heart, lung, blood, and sleep (HLBS) disorders and diseases, including greater cardiovascular disease (CVD)-specific and overall premature mortality. The Strong Heart Study (SHS) was initiated in 1988 following the recommendations of the Subcommittee on Cardiovascular and Cerebrovascular Disease of the Secretary of Health and Human Services’ Task Force on Black and Minority Health that concluded information on CVD in NA populations was inadequate. The SHS is a longitudinal observational study of two (2) combined cohorts followed prospectively: the original SHS cohort recruited in 1989 to 1991, and a Strong Heart Family Study (SHFS) cohort recruited in 1998 to 1999. The original and family cohorts together form the largest, multicenter, prospective epidemiological study of cardiovascular disease (CVD) in Native Americans/American Indians. The study’s main objective is to examine the etiology and natural history of cardiovascular disease. The terms Native Americans (NA) and American Indians (AIs) will be used throughout this document. Overall, there have been seven phases of the study, with each phase corresponding to a multi-year project period. In Phase I, the original SHS recruited 4,549 participants without regard to disease status from 13 Tribes and communities in three (3) geographic regions in the US: Oklahoma (OK), Arizona (AZ), and the Dakotas (ND) and (SD). The original cohort was comprised of unrelated participants that were examined three times from 1989 to 1999 (once each in Phases I through III). The objectives were to estimate cardiovascular disease morbidity and mortality, as well as incidence and prevalence of known and suspected cardiovascular risk factors in AIs, and to assess the significance of these risk factors.
The SHFS was initiated to complement the original SHS by investigating the heritability of CVD and its risk factors and by identifying genetic variants influencing variation in phenotypic risk factors of obesity, diabetes, and CVD found to be highly prevalent in the original SHS cohort. A pilot family study was successfully conducted in Phase III, with the full-scale SHFS study (with expanded participant recruitment) beginning in Phase IV. A total of 3,790 participants from 94 multigenerational families were recruited in the full-scale SHFS, including 14 participants who were also members of
The beginning of the document. Download the full file to read on.